Solid Biosciences (SLDB) Cash & Equivalents (2017 - 2026)
Quarterly results put Cash & Equivalents at $297.1 million for Q1 2026, up 41.05% from a year ago — trailing twelve months through Mar 2026 was $297.1 million (up 41.05% YoY), and the annual figure for FY2025 was $59.9 million, down 25.34%.
Solid Biosciences has reported Cash & Equivalents over the past 10 years, most recently at $297.1 million for Q1 2026.
- Cash & Equivalents reached $297.1 million in Q1 2026 per SLDB's latest filing, up from $59.9 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $297.1 million in Q1 2026 and bottomed at $48.8 million in Q3 2022.
- Median Cash & Equivalents over the past 5 years was $91.6 million (2023), compared with a mean of $111.4 million.
- The largest annual shift saw Cash & Equivalents tumbled 72.93% in 2022 before it skyrocketed 79.15% in 2025.
- Over 5 years, Cash & Equivalents stood at $155.4 million in 2022, then plummeted by 52.37% to $74.0 million in 2023, then rose by 8.4% to $80.2 million in 2024, then dropped by 25.34% to $59.9 million in 2025, then surged by 395.99% to $297.1 million in 2026.
- Business Quant data shows Cash & Equivalents for SLDB at $297.1 million in Q1 2026, $59.9 million in Q4 2025, and $61.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 1.91 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 901.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 5.49 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 2.96 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.71 Bn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | 297.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 297.10 Mn |
| Dec 31, 2025 | 59.90 Mn |
| Sep 30, 2025 | 61.36 Mn |
| Jun 30, 2025 | 138.93 Mn |
| Mar 31, 2025 | 210.63 Mn |
| Dec 31, 2024 | 80.24 Mn |
| Sep 30, 2024 | 64.39 Mn |
| Jun 30, 2024 | 95.85 Mn |
| Mar 31, 2024 | 117.57 Mn |
| Dec 31, 2023 | 74.02 Mn |
| Sep 30, 2023 | 49.04 Mn |
| Jun 30, 2023 | 91.57 Mn |
| Mar 31, 2023 | 164.65 Mn |
| Dec 31, 2022 | 155.38 Mn |
| Sep 30, 2022 | 48.79 Mn |
| Jun 30, 2022 | 54.31 Mn |
| Mar 31, 2022 | 129.71 Mn |
| Dec 31, 2021 | 119.14 Mn |
| Sep 30, 2021 | 109.68 Mn |
| Jun 30, 2021 | 200.61 Mn |
| Mar 31, 2021 | 268.50 Mn |
| Dec 31, 2020 | 155.07 Mn |
| Sep 30, 2020 | 24.80 Mn |
| Jun 30, 2020 | 40.77 Mn |
| Mar 31, 2020 | 53.51 Mn |
| Dec 31, 2019 | 76.04 Mn |
| Sep 30, 2019 | 95.05 Mn |
| Jun 30, 2019 | 52.16 Mn |
| Mar 31, 2019 | 54.32 Mn |
| Dec 31, 2018 | 86.37 Mn |
| Sep 30, 2018 | 129.37 Mn |
| Jun 30, 2018 | 146.06 Mn |
| Mar 31, 2018 | 165.08 Mn |
| Dec 31, 2017 | 52.15 Mn |
| Sep 30, 2017 | 15.02 Mn |
| Jun 30, 2017 | 32.72 Mn |
| Mar 31, 2017 | 29.27 Mn |